Kymera Therapeutics Inc (KYMR) — Cash Flow Reinvestment Rate
Kymera Therapeutics Inc (KYMR) has a Cash Flow Reinvestment Rate of 3.80x as of December 2023, reinvesting $30.58 Million (capex $11.62 Million plus investments $18.95 Million) from operating cash flow of $8.04 Million. See Kymera Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kymera Therapeutics Inc Cash Flow Reinvestment Rate (2019–2020)
Historical reinvestment intensity for Kymera Therapeutics Inc across 2 annual periods. For the full cash flow conversion analysis, see how efficiently does Kymera Therapeutics Inc generate cash.
Annual Cash Flow Reinvestment Rate for Kymera Therapeutics Inc (2019–2020)
Year-by-year capital reinvestment analysis for Kymera Therapeutics Inc. See financial agility of Kymera Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 4.90x | $431.68 Million | $88.13 Million | $9.10 Million | ▲ +432.0% |
| 2019 | 0.92x | $16.49 Million | $17.91 Million | $532.00K | — |